Result of AGM

RNS Number : 4898N

IXICO plc

18 January 2019

 

18 January 2019

IXICO plc

("IXICO" or the "Company")

Results of AGM

IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.

For further information please contact:

IXICO plc Giulio Cerroni, Chief Executive Officer	Tel: [phone]
Shore Capital (Nomad and Broker) Edward Mansfield / Anita Ghanekar / Daniel Bush	Tel: [phone]
FTI Consulting Limited (Investor Relations) Simon Conway	Tel: [phone]

About IXICO

IXICO is dedicated to delivering insights in neuroscience. Our mission is to transform the progression of our biopharmaceutical clients' neurological therapeutic pipelines through the application of novel medical imaging and mobile health digital technologies.

IXICO's data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable better trial design, site qualification, patient selection and clinical outcomes. We provide technology-enabled services across all phases of clinical evaluation. Our integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make rapid, better informed decisions. IXICO is also collaborating with partners to develop new analytical techniques and companion digital health products targeted at improving patient outcomes.

More information is available on www.IXICO.com

 

END

 

 

RAGCKFDDFBKKDDD